Novabay Pharmaceuticals Incorporated (NYSEMKT:NBY) had an increase of 15.63% in short interest. NBY’s SI was 131,700 shares in April as released by FINRA. Its up 15.63% from 113,900 shares previously. With 20,600 avg volume, 6 days are for Novabay Pharmaceuticals Incorporated (NYSEMKT:NBY)’s short sellers to cover NBY’s short positions. The SI to Novabay Pharmaceuticals Incorporated’s float is 2.69%. The stock decreased 1.47% or $0.05 on April 27, reaching $3.35. About shares traded. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) has declined 10.43% since September 21, 2016 and is downtrending. It has underperformed by 20.86% the S&P500.
Artisan Partners Limited Partnership increased Baidu Inc (BIDU) stake by 7.98% reported in 2016Q4 SEC filing. Artisan Partners Limited Partnership acquired 518,444 shares as Baidu Inc (BIDU)’s stock declined 10.42%. The Artisan Partners Limited Partnership holds 7.02 million shares with $1.15 billion value, up from 6.50M last quarter. Baidu Inc now has $65.13 billion valuation. The stock increased 0.64% or $1.19 during the last trading session, reaching $187.86. About 6,160 shares traded. Baidu Inc (ADR) (NASDAQ:BIDU) has declined 4.17% since September 21, 2016 and is downtrending. It has underperformed by 14.60% the S&P500.
Artisan Partners Limited Partnership decreased Fluor Corp New (NYSE:FLR) stake by 124,210 shares to 2.69M valued at $141.28M in 2016Q4. It also reduced Dollar Gen Corp New (NYSE:DG) stake by 334,869 shares and now owns 296,055 shares. Tractor Supply Co (NASDAQ:TSCO) was reduced too.
Among 22 analysts covering Baidu (NASDAQ:BIDU), 6 have Buy rating, 4 Sell and 12 Hold. Therefore 27% are positive. Baidu had 35 analyst reports since July 28, 2015 according to SRatingsIntel. Cantor Fitzgerald initiated Baidu Inc (ADR) (NASDAQ:BIDU) on Monday, December 19 with “Underweight” rating. Oppenheimer maintained Baidu Inc (ADR) (NASDAQ:BIDU) on Monday, August 3 with “Outperform” rating. The stock has “Buy” rating by Jefferies on Thursday, May 12. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, January 10. The rating was downgraded by Morgan Stanley on Tuesday, January 17 to “Equal-Weight”. Nomura downgraded it to “Neutral” rating and $180 target in Friday, January 22 report. Summit Research downgraded Baidu Inc (ADR) (NASDAQ:BIDU) on Wednesday, September 30 to “Hold” rating. Macquarie Research maintained Baidu Inc (ADR) (NASDAQ:BIDU) on Monday, May 2 with “Outperform” rating. The company was downgraded on Wednesday, September 28 by Deutsche Bank. The rating was downgraded by Pacific Crest on Tuesday, July 28 to “Sector Weight”.
NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The company has market cap of $51.11 million. The Firm focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. It currently has negative earnings. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox.
